Haemonetics Q3 Results Top Estimates - Quick Facts

(RTTNews) - Healthcare company Haemonetics Corp. (HAE) reported Tuesday that net income for the third quarter grew to $31.88 million or $0.62 per share from $29.90 million or $0.58 per share in the prior-year quarter. Excluding items, adjusted earnings were $0.81 per share, compared to last year's $0.94 per share.

Net revenue for the quarter decreased 7.2 percent to $240.37 million from last year's $258.97 million, primarily driven by the continued negative impact of COVID-19. Organic revenue was down 5.7 percent.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.65 per share on revenue of $224.29 million for the quarter. Analysts' estimates typically exclude special items.